Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-28

Clinical Trial Update: A New Clinical Use of Ferumoxytol Nanoparticles: An Antibiofilm Treatment [Phase 4]

View source ↗

Summary

Phase 4 trial reports results on using ferumoxytol nanoparticles as an antibiofilm treatment for dental conditions, including apical periodontitis and dental pu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FERUMOXYTOL (ferumoxytol)

Snippet

Sponsor: University of Pennsylvania | Conditions: Apical Periodontitis, Pulp Disease, Dental | Phase 4 | Status: COMPLETED | Results posted: 2024-08-28